Replies to post #14540 on ANI Pharmaceuticals (ANIP)

[silvr_surfr]

Thanks JTFM. The Brits are serious about "the menopause." A couple of things I came across recently about this:

Androfemme was given an exemption and allowed to be imported from Australia.

Lawley said that they would be submitting Androfemme for approval in the "near future". Maybe the notes you shared indicate that this was rejected because of incomplete safety data. This makes our data all the more valuable.

There is an office app that was created there that allows the patient and doctor to quickly get at the key menopausal or HSDD symptoms in a standardized way. This would make the appointment times shorter and no doubt the app will have a bias toward prescribing medication.